A Study to Evaluate the Effectiveness of Essure Post-NovaSure Radiofrequency Endometrial Ablation Procedure Following a Successful Essure Confirmation Test



Status:Active, not recruiting
Conditions:Contraception
Therapuetic Areas:Reproductive
Healthy:No
Age Range:21 - 50
Updated:4/6/2019
Start Date:November 13, 2012
End Date:July 31, 2021

Use our guide to learn which trials are right for you!

The purpose of the post approval study is to evaluate the effectiveness and safety of the
Essure System when a NovaSure Endometrial Ablation procedure is performed following a
successful Essure Confirmation Test.

This study has previously been posted by Conceptus, Inc. After acquiring Conceptus, Inc.,
Bayer is now the sponsor of the trial.

Inclusion Criteria:

- All inclusion criteria from the Essure Permanent Birth Control System Instructions for
Use and/or the NovaSure Impedance Controlled Endometrial Ablation (EA) System
Instructions for Use and Controller Operator's Manual will apply.

- Women experiencing menorrhagia due to benign causes

- Women who are relying on the Essure micro-inserts for permanent contraception
following a successful Essure Confirmation Test (as applicable to the Post Approval
Study)

- Women willing to accept the risk of pregnancy while relying on the Essure
micro-inserts for prevention of pregnancy following a NovaSure ablation procedure for
menorrhagia

Exclusion Criteria:

- All exclusion criteria from the Essure Permanent Birth Control System Instructions for
Use and/or the NovaSure Impedance Controlled Endometrial Ablation System Instructions
for Use and Controller Operator's Manual will apply.

- Women who previously underwent a fallopian tube sterilization procedure (other than
Essure placement)

- Women who present with any other medical complaints, conditions or symptoms unrelated
to the Essure System and/or subsequent NovaSure EA including, but not limited to:

- Gynecological co-morbidities (e.g., pelvic infection, cervicitis, undiagnosed
vaginal bleeding, endometrial cancer, myomas, and polyps)

- Reproductive tract anatomical variants and/or pathology which could make the
subject unsuitable for the Essure and/or NovaSure transcervical procedures

- Women currently wearing an intrauterine device and unwilling to have it removed before
NovaSure
We found this trial at
19
sites
?
mi
from
Ocala, FL
Click here to add this to my saved trials
?
mi
from
Aurora, CO
Click here to add this to my saved trials
?
mi
from
Decatur, IL
Click here to add this to my saved trials
?
mi
from
Easton, MD
Click here to add this to my saved trials
?
mi
from
Englewood, OH
Click here to add this to my saved trials
?
mi
from
Fort Wayne, IN
Click here to add this to my saved trials
?
mi
from
Grand Blanc, MI
Click here to add this to my saved trials
?
mi
from
Las Vegas, NV
Click here to add this to my saved trials
?
mi
from
Maplewood, MN
Click here to add this to my saved trials
?
mi
from
Mason, OH
Click here to add this to my saved trials
?
mi
from
Nashville, TN
Click here to add this to my saved trials
?
mi
from
Nashville, TN
Click here to add this to my saved trials
?
mi
from
Neptune, NJ
Click here to add this to my saved trials
?
mi
from
Newburgh, IN
Click here to add this to my saved trials
?
mi
from
Norfolk, VA
Click here to add this to my saved trials
?
mi
from
Pottstown, PA
Click here to add this to my saved trials
?
mi
from
Spokane, WA
Click here to add this to my saved trials
?
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
?
mi
from
Winston-Salem, NC
Click here to add this to my saved trials